The COVID-19 crisis changed the way people work across industries including the pharma industry. MD Analytics teamed up with the professional association for women in the pharma industry Women Leaders in Pharma to conduct a study on the impact on of COVID-19 on women who work in the pharma industry.
We asked 180 Canadian physicians of which pharmaceutical company they have the highest opinion. Overall, there was no clear winner. However, when asked by disease areas, some leaders emerge.
Top companies seen as leader in…(% ranked 1-3)
- Neurology: Novartis (46%); Roche (38%); Lilly (37%)
- Cardiovascular Disease: Merck (51%); AstraZeneca (43%); Pfizer (43%)
- Respiratory: GSK (69%); AstraZeneca (67%); Boehringer Ingelheim (56%)
- Gastroenterology: Merk (67%); Pfizer (61%); Janssen (56%)
- Diabetes: Lilly (50%); Novo Nordisk (40%); AstraZeneca (37%)
- Psoriasis: Leo (65%); Galderma (57%); Janssen (24%)
Past Quick Polls
The COVID-19 vaccination campaign is underway in Canada. However, the pandemic has significantly altered HCPs’ practices to date. These changes have impacted workloads, patient assessments, and interactions with pharma. A year into the pandemic, a national COVID-19 vaccination campaign is underway. This begs the question, how are Canadian HCPs doing today? What do they foresee moving forward? Our latest short survey presents the current state of HCPs’ practices in Canada and their assessment of the government’s management of COVID-19.
Our 5-minute online survey conducted in the fall of 2020 sought to gain clarity around remote detailing. This study was conducted with 339 Canadian physicians who are members of the MD Analytics healthcare panel and the results provide actionable recommendations on how to form a more ‘ideal’ pharma remote detail.
The COVID-19 crisis has significantly impacted physicians’ practices; but how and to what extent? Physicians have been managing significant workloads, while learning on the fly how to navigate and setup virtual meetings. Maintaining high levels of patient care while minimizing in-person interactions has also been challenging.